Endocyte Inc. | Mutual Funds
Mutual Funds that own Endocyte Inc.
Vanguard Total Stock Market Index Fund
1,619,329
2.31%
0
0%
07/31/2018
iShares Russell 2000 ETF
1,360,357
1.94%
-726
0.06%
09/06/2018
iShares Nasdaq Biotechnology ETF
802,077
1.14%
-10,479
0.16%
09/06/2018
Vanguard Extended Market Index Fund
799,320
1.13%
4,500
0.02%
07/31/2018
iShares Russell 2000 Growth ETF
576,983
0.82%
0
0.1%
09/06/2018
Fidelity Select Biotechnology Portfolio
504,315
0.72%
-177,000
0.11%
07/31/2018
PowerShares DWA Healthcare Momentum Portfolio
466,427
0.67%
22,212
2.98%
09/05/2018
SPDR S&P Pharmaceuticals ETF
447,891
0.64%
0
2.15%
09/06/2018
PowerShares DWA Small Cap Momentum Portfolio
366,802
0.52%
0
1.59%
09/05/2018
Eventide Healthcare & Life Sciences Fund
350,000
0.5%
0
1%
06/29/2018
| Address |
3000 Kent Avenue
West Lafayette Indiana 47906
United States
|
|
Employees
|
- |
| Website |
http://www.endocyte.com |
| Updated |
09/14/2018 |
| Endocyte, Inc. is a biopharmaceutical company, which engages in the development of targeted therapies for the treatment of cancer and inflammatory diseases. It uses a proprietary technology to create novel small molecule drug conjugates and companion imaging diagnostics for personalized targeted therapies. Its small molecule drug conjugates are actively target receptors that are over-expressed on diseased cells. |
